Breo Ellipta (Fluticasone Furoate/Vilanterol) Medication Information
Breo Ellipta contains two different medications, called fluticasone furoate and vilanterol. It is approved for the maintenance treatment of the inflammatory lung conditions asthma and chronic obstructive pulmonary disease (COPD).
Breo Ellipta controls symptoms like cough, wheezing, and shortness of breath. It is a daily medication that reduces the need for rescue inhalers like albuterol.
Breo Ellipta contains an inhaled corticosteroid (ICS) and a long-acting beta-agonist (LABA). The ICS decreases inflammation in the lungs, which relaxes the airways and makes it easier to breathe. The LABA relaxes the smooth muscles of the lungs and opens the airways.
Breo Ellipta inhalers come in two different sizes, including fluticasone furoate/vilanterol 200 mcg/25 mcg and 100 mcg/25 mcg. Your doctor will prescribe one of these sizes.
Inhale the contents of one blister pack by mouth once daily. Use Breo Ellipta every day, even if you don’t have symptoms.
Common side effects of Breo Ellipta include:
- Back pain
- Dysphonia Cough
- Oral candidiasis
- Oropharyngeal pain
- Upper respiratory tract infection
Breo Ellipta is not a rescue inhaler and should not be used for an “attack” or acute bronchospasm. Bronchospasms should be treated with a short-acting beta-agonist like albuterol.
Breo Ellipta inhalation contains milk proteins, so do not use if you have hypersensitivity to milk or whey.
Rinse the mouth with water after each use and spit the water out without swallowing. Rinsing will help prevent the development of oral thrush.
People with COPD are at an increased risk of pneumonia when they take Breo Ellipta.
Tell your doctor if you have a latent infection, including tuberculosis, ocular herpes simplex, or other infections.
In some rare cases, Breo Ellipta can cause bronchospasm. If this happens, stop taking it and tell your doctor.
Tell your doctor if you have a history of glaucoma.
Drug interactions are rare with Breo Ellipta because it does not absorb into the bloodstream. However, interactions can still happen if you are taking the following medications:
- Monoamine oxidase inhibitors
- Tricyclic antidepressants
Store Breo Ellipta at room temperature between 68°F and 77°F (20°C and 25°C).
- After inhalation, hold your breath for at least 3 to 4 seconds to let the medication absorb into the lungs
- To “prime” the inhaler, open the cover until it clicks. This loads a dose of medication that is ready for inhalation.
- Only open the cover when you are ready to inhale your dose. If you close the cover without using the dose, it will be lost.
Breo Ellipta FAQs
When should I remove the inhaler from the sealed tray?
Breo Ellipta comes packaged in a sealed tray with a desiccant to prevent moisture from getting into the inhaler. Once you take it out of the tray, it should be discarded after six weeks.
How many doses are in each inhaler?
Each inhaler has 30 inhalations, and you can tell how many are left by reading the dosage counter.
How long does it take for this to work?
You should notice the effects of Breo Ellipta within 1-2 weeks of daily use.